PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 139 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,810 | -99.9% | 500,000 | -37.5% | 0.43% | -46.0% |
| Q1 2022 | $18,946,000 | -55.7% | 800,100 | -36.0% | 0.79% | -31.6% |
| Q4 2021 | $42,750,000 | +60.8% | 1,250,000 | -16.7% | 1.16% | +95.0% |
| Q3 2021 | $26,580,000 | +1268.0% | 1,500,000 | +1900.0% | 0.60% | +1650.0% |
| Q1 2021 | $1,943,000 | -27.5% | 75,000 | -43.6% | 0.03% | -41.4% |
| Q4 2020 | $2,681,000 | +3.1% | 133,000 | 0.0% | 0.06% | -7.9% |
| Q3 2020 | $2,600,000 | +5.2% | 133,000 | -5.0% | 0.06% | -8.7% |
| Q2 2020 | $2,472,000 | – | 140,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |